|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Acne | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Acne Vulgaris | |||||
| 3 | More general conditions related to this trial | ||||
| Acneiform Eruptions | |||||
| Facial Dermatoses | |||||
| Sebaceous Gland Diseases | |||||
| Skin Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Azelaic Acid | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antineoplastic Agents | |||||
| Dermatologic Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Bayer | |||||